Ischemic Stroke Clinical Trials

189 recruiting

Ischemic Stroke Trials at a Glance

357 actively recruiting trials for ischemic stroke are listed on ClinicalTrialsFinder across 6 cities in 61 countries. The largest study group is Not Applicable with 128 trials, with the heaviest enrollment activity in Beijing, Beijing, and Guangzhou. Lead sponsors running ischemic stroke studies include Capital Medical University, Beijing Tiantan Hospital, and Kafrelsheikh University.

Browse ischemic stroke trials by phase

Treatments under study

About Ischemic Stroke Clinical Trials

Looking for clinical trials for Ischemic Stroke? There are currently 189 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ischemic Stroke trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ischemic Stroke clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 357 trials

Recruiting

Continuous Dual Aspiration Technique With Zoom System for Stroke

Acute StrokeIschemic Stroke
Imperative Care, Inc.750 enrolled9 locationsNCT07491952
Recruiting
Phase 2

Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd300 enrolled28 locationsNCT05686642
Recruiting
Not Applicable

Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion

Acute Ischemic Stroke
Jinling Hospital, China386 enrolled1 locationNCT05903560
Recruiting
Not Applicable

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

Atrial FibrillationIschemic Stroke
Insel Gruppe AG, University Hospital Bern482 enrolled28 locationsNCT05976685
Recruiting
Not Applicable

Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS

Mild Neurocognitive DisorderThrombectomyAcute Ischemic Stroke
First Affiliated Hospital of Wannan Medical College264 enrolled1 locationNCT06143488
Recruiting
Phase 3

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

Acute Ischemic Stroke
Boehringer Ingelheim1,325 enrolled224 locationsNCT07361302
Recruiting
Phase 2

Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke

Acute Ischemic Stroke
University of California, Los Angeles120 enrolled3 locationsNCT06440707
Recruiting
Phase 3

Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke

Ischemic StrokeMedium Vessel OcclusionEndovascular Treatment+1 more
Beijing Tiantan Hospital488 enrolled1 locationNCT07357987
Recruiting
Phase 2Phase 3

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

StrokeAcute StrokeIschemic Stroke
DiaMedica Therapeutics Inc728 enrolled66 locationsNCT05065216
Recruiting
Phase 4

Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients

Acute Ischemic Stroke Patients
Southwest Hospital, China798 enrolled49 locationsNCT07294209
Recruiting

Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults

Ischemic StrokeHemorrhagic Stroke
Shanghai 6th People's Hospital60 enrolled2 locationsNCT05113043
Recruiting
Not Applicable

Direct Ischemic Conditioning for Endovascular Recanalization for Anterior Large Vessel Occlusion (DICER-aLVO)

Ischemic Stroke
General Hospital of Shenyang Military Region120 enrolled1 locationNCT06940128
Recruiting
Not Applicable

Balloon Angioplasty for Minor Unstable Stroke With IntraCranial Atherosclerosis Stenosis (BAMUS-ICAS)

Ischemic Stroke
General Hospital of Shenyang Military Region100 enrolled1 locationNCT06763458
Recruiting
Phase 4

A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment

Ischemic Stroke HospitalizedImpairment, Cognitive
Dr. Willmar Schwabe GmbH & Co. KG400 enrolled30 locationsNCT07220538
Recruiting

The Impact of Anti-thrombosis on Cerebral Microbleeds and Intracranial Hemorrhage in Ischemic Stroke Patients

Ischemic Stroke
General Hospital of Shenyang Military Region1,875 enrolled1 locationNCT03571763
Recruiting
Not Applicable

Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke

Ischemic Stroke
General Hospital of Shenyang Military Region960 enrolled1 locationNCT06931535
Recruiting
Phase 3

Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

Ischemic Stroke
Kafrelsheikh University600 enrolled1 locationNCT06358313
Recruiting

Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke

Acute Ischemic Stroke
First Affiliated Hospital of Harbin Medical University1,000 enrolled1 locationNCT07540741
Recruiting
Phase 3

Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke

Ischemic Stroke
Capital Medical University348 enrolled6 locationsNCT07509645
Recruiting
Phase 2

A Study of TAK-755 in Adults With Acute Ischemic Stroke

Acute Ischemic Stroke
Takeda222 enrolled1 locationNCT07392450